oncology-pharma.com | Home | Oncology Pharma

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.oncology-pharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Home \| Oncology Pharma
Description	top of page Home White Papers Science & Tech Management Advisory Board Portfolio News Contact Blog Oncology Pharma Inc. Oncology Pharma, Inc. is a pioneer
Keywords	N/A

Server Information

WebSite	oncology-pharma.com
Host IP	185.230.63.186
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

oncology-pharma.com Valuation

US$7,616,623

Last updated: 2023-05-02 05:23:29

oncology-pharma.com has Semrush global rank of 1,389,632. oncology-pharma.com has an estimated worth of US$ 7,616,623, based on its estimated Ads revenue. oncology-pharma.com receives approximately 878,842 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, oncology-pharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$7,616,623
Daily Ads Revenue	US$7,031
Monthly Ads Revenue	US$210,922
Yearly Ads Revenue	US$2,531,063
Daily Unique Visitors	58,590
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
oncology-pharma.com.	A	3599	IP: 185.230.63.186
oncology-pharma.com.	A	3599	IP: 185.230.63.171
oncology-pharma.com.	A	3599	IP: 185.230.63.107
oncology-pharma.com.	NS	86400	NS Record: ns15.wixdns.net.
oncology-pharma.com.	NS	86400	NS Record: ns14.wixdns.net.
oncology-pharma.com.	MX	3600	MX Record: 10 mx.hover.com.cust.hostedemail.com.

HtmlToTextCheckTime:2023-05-02 05:23:29

top of page Home White Papers Science & Tech Management Advisory Board Portfolio News Contact Blog Oncology Pharma Inc. Oncology Pharma, Inc. is a pioneering oncology company dedicated to licensing, developing, manufacturing and commercializing therapeutics. The company has assembled a team of executives and advisors with proven multi-disciplinary expertise in the field of oncology, therapeutics and leadership to identify, negotiate and amalgamate “best in class” research, technologies, therapeutics and delivery mechanisms that are synergistic and collaborative. The goal is to create value, reduce costs and increase the speed of regulatory approval and commercialization of effective and safer cancer drugs. Oncology Pharma entered into a Licensing Agreement with NanoSmart®Pharmaceuticals Inc. for its "novel" drug delivery platform that can target many types of cancer and other diseases. One of the keys to NanoSmart’s® platform technology is a “patented”(US 7,799,327 and EU 1706145

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sun, 24 Oct 2021 16:56:26 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.oncology-pharma.com/
strict-transport-security: max-age=120
x-wix-request-id: 1635094586.0233174521842828817
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVivd4o9HMoDTVPhK7/s60Jl,m0j2EEknGIVUW/liY8BLLl3+z1LPCVX20aGaUcDWZPwcm7On4dir39PTYYK13tG9,2d58ifebGbosy5xc+FRalgbB2i1Mob0nPtSLeBuq1ZXvTdHFWbEEgTtHlYGrNUOSWgndP/ZjosE/i9WZ31WkMg==,2UNV7KOq4oGjA5+PKsX47Br+ilU2OUaGN9cE2DqPolkfbJaKSXYQ/lskq2jK6SGP,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,qJS91GsscGZlb16v+8nwmI77owKHA5L0OSbRVxtr6utGp/J3MBzgzU8QHrQuh4zQ,UvY1uiXtmgas6aI2l+unv0zydNlQILr+5azqKbsn+TJ8Oli2AcZQeWeYBGqIsp3nSYblWJ1+I4NCiXX+q5JMPA==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
alt-svc: h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"1f463bdaca2a7055448c908481378e06"
content-language: en-US
strict-transport-security: max-age=120
x-wix-request-id: 1635094586.3103960254265305
cache-control: public,max-age=0,must-revalidate
x-content-type-options: nosniff
server: Pepyaka/1.19.10
accept-ranges: bytes
date: Sun, 24 Oct 2021 16:56:26 GMT
age: 68381
x-served-by: cache-chi21182-CHI
x-cache: MISS
vary: Accept-Encoding
server-timing: cache;desc=hit, varnish;desc=hit_miss, dc;desc=fastly
set-cookie: ssr-caching=cache#desc=hit#varnish=hit_miss#dc#desc=fastly; Max-Age=20; Expires=Sat, 23 Oct 2021 21:57:04 GMT
x-seen-by: roqoaVaG/Y0K4FDXPQbYVA==,GXNXSWFXisshliUcwO20NYMupe6WQf6MVMrzEUOojIJApWd1FlscnvvmzjBAZbfy,qquldgcFrj2n046g4RNSVFCyQoc+8a4IB0r6FC3J5Wc=,2d58ifebGbosy5xc+FRalmmkN+BH277cb3XUrnMB6DGBoE6f6IwZO0lgzcKialPZ9Jk7hMg3mdY4GRdI1MoA+R4O97PfDZwIfyXXcFvER8A=,2UNV7KOq4oGjA5+PKsX47BKn5Yg4ON9Aa7djl3ltpSdYgeUJqUXtid+86vZww+nL
content-length: 394639

oncology-pharma.com Whois Information

Domain Name: ONCOLOGY-PHARMA.COM
Registry Domain ID: 2368612993_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucows.com
Updated Date: 2021-03-11T10:37:15Z
Creation Date: 2019-03-12T18:05:37Z
Registry Expiry Date: 2022-03-12T18:05:37Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.WIXDNS.NET
Name Server: NS2.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T23:27:36Z <<<

oncology-pharma.com valuation and analysis